RedHill Biopharma Ltd. Quarterly Liabilities in USD from Q4 2016 to Q4 2023

Taxonomy & unit
ifrs-full: USD
Summary
RedHill Biopharma Ltd. quarterly Liabilities history and growth rate from Q4 2016 to Q4 2023.
  • RedHill Biopharma Ltd. Liabilities for the quarter ending December 31, 2023 was $21M, a 89.9% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $21M -$186M -89.9% Dec 31, 2023 20-F 2024-04-08
Q2 2023 $31.6M -$148M -82.5% Jun 30, 2023 6-K 2023-08-17
Q4 2022 $207M +$35M +20.3% Dec 31, 2022 20-F 2024-04-08
Q2 2022 $180M +$5.82M +3.34% Jun 30, 2022 6-K 2022-11-07
Q4 2021 $172M +$5.94M +3.57% Dec 31, 2021 20-F 2023-04-28
Q2 2021 $174M +$42.3M +32.1% Jun 30, 2021 6-K 2021-08-26
Q4 2020 $166M +$152M +1080% Dec 31, 2020 20-F 2022-03-17
Q2 2020 $132M +$114M +641% Jun 30, 2020 6-K 2020-08-13
Q4 2019 $14.1M +$2.87M +25.6% Dec 31, 2019 20-F 2021-03-18
Q2 2019 $17.8M +$5.85M +49% Jun 30, 2019 6-K 2019-07-23
Q4 2018 $11.2M -$1.05M -8.58% Dec 31, 2018 20-F 2020-03-04
Q2 2018 $11.9M Jun 30, 2018 6-K 2018-08-30
Q4 2017 $12.3M +$767K +6.66% Dec 31, 2017 20-F 2019-02-26
Q4 2016 $11.5M Dec 31, 2016 20-F 2018-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.